Active ingredients: umeclidinium
What it is used for
Incruse Ellipta is indicated as a long term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Inhalation
- Store below 30 degrees Celsius
- See Product information for shelf life
- Lifetime is 24 Months.
Always read the label. If symptoms persist see your healthcare professional.
A plastic inhaler with a light grey body and a light green mouthpiece cover containing one strip of blister containing a white powder.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
Is this medicine subsidised?
This medicine is subsidised which may make it cheaper. To learn more about this subsidy, visit the Phamaceutical Benefits Scheme (PBS) website
Pregnant or planning a pregnancy?
For the active ingredient umeclidinium
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)
Incruse Ellipta Powder for inhalation - myDr.com.au
Incruse Ellipta Powder for inhalation - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
COPD: treatment and management - myDr.com.au
Although COPD cannot be cured, there are measures that can be taken that should relieve symptoms, slow progression and prevent complications.
Read more on myDr website